Private Equity Firm Healthcare

Signet Healthcare Partners

New York, New York, United States

Signet Healthcare Partners is a healthcare growth equity firm that provides growth capital to commercial-stage healthcare companies, primarily in pharmaceuticals and medical technology.

Focus Areas
Pharmaceuticals, Medical technology

Tracked deals

5

5 tracked deals across 2021-2025.

Recent pace

1

1 tracked deal announced in the last 12 months.

Deal mix

Growth capital

2 growth capital · 1 addon · 1 divestiture

Signet Healthcare Partners Acquisition Volume by Year

Last 3 years

Acquisition volume by year Annual acquisition counts for the last 3 years for Signet Healthcare Partners. 1 2021 3 2022 1 2025

Supporting Data

Recent Transactions

  • Buyer
    Signet Healthcare Partners, Windham Capital Partners, MVolution Partners
    Target
    PainTEQ
    Industry
    Medical Devices

    PainTEQ, a Tampa-based developer of minimally invasive sacroiliac (SI) joint implants, completed a majority growth recapitalization co-led by Signet Healthcare Partners and Windham Capital Partners with a new equity investment from MVolution Partners. The capital will fund clinical studies, next-generation product development and expansion of PainTEQ's U.S. commercial presence; transaction terms were not disclosed.

  • Buyer
    Laborie Medical Technologies Corp., Patricia Industries, Signet Healthcare Partners
    Target
    GI Supply
    Industry
    Medical Devices
    Type
    Addon

    Laborie Medical Technologies has completed the acquisition of GI Supply, a specialist maker of endoscopy and paracentesis products. GI Supply and its employees will be fully integrated into Laborie to expand the company's gastroenterology product portfolio and commercial capabilities; the deal is supported by Laborie's majority owner Patricia Industries and growth-equity partner Signet Healthcare Partners.

  • Buyer
    Signet Healthcare Partners
    Target
    Juno Pharmaceuticals Corp.
    Industry
    Pharmaceuticals
    Location
    Quebec, Canada

    Signet Healthcare Partners, a New York-based healthcare growth equity firm, has completed a growth equity investment in Canadian specialty generics company Juno Pharmaceuticals Corp. Juno will use the proceeds to expand its complex and high-value generic and biosimilar portfolio and accelerate its growth and pipeline development in Canada and international markets.

  • Buyer
    Signet Healthcare Partners, Bionpharma, Inc., GMS Capital Partners LLC, Pharma Nobis, LLC
    Target
    Fagron's U.S. contract manufacturing business and manufacturing facility (Texarkana, Texas)
    Seller
    Fagron
    Industry
    Pharmaceuticals

    An investor consortium led by Signet Healthcare Partners with Bionpharma, Inc. and GMS Capital Partners formed Pharma Nobis, LLC to acquire Fagron's U.S. contract manufacturing business and manufacturing facility in Texarkana, Texas. Fagron will retain a 20% interest in the new company; Todd Daviau was named CEO and the investors said they will seek to grow the contract manufacturing and private-label capabilities for consumer healthcare and retail customers.

  • Buyer
    Signet Healthcare Partners
    Target
    Ascendia Pharmaceuticals, Inc.
    Industry
    Pharmaceuticals

    Signet Healthcare Partners, a New York-based growth equity firm, has made a growth equity investment in Ascendia Pharmaceuticals, a North Brunswick, New Jersey-based specialty CDMO. The proceeds will fund Ascendia's facility expansion and increased manufacturing capacity; Signet principals James Gale and Dr. Theron Odlaug will join Ascendia's board.

Related Acquisition Pages

Selling a company? Get in front of buyers like Signet Healthcare Partners

Turn tracked acquisition activity into an outreach-ready buyer list.